HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties

Journal of Biological Chemistry

Volumn 287, Issue 29, 2012, Pages 24320-24329

  Recktenwald, Christian V ^a   Leisz, Sandra ^a   Steven, André ^a   Mimura, Kousaku ^b   Müller, Anja ^a   Wulfänger, Jens ^a   Kiessling, Rolf ^b   Seliger, Barbara ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAMP-RESPONSE ELEMENT-BINDING PROTEINS; CELLULAR MIGRATION; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEIN; GROWTH PROPERTIES; HUMAN TUMORS; IN-VITRO; ISOFORMS; MAP KINASE; MATRIX ASSEMBLY; NEOPLASTIC TRANSFORMATION; ONCOGENIC TRANSFORMATION; PKC SIGNALING; PROTEIN KINASE C; PROTEOGLYCANS; RNA INTERFERENCE; TARGET PROTEINS; TRANSFORMING GROWTH FACTORS; WOUND CLOSURE;

CELL CULTURE; CELL DEATH; ENZYMES; GLYCOPROTEINS; RNA;

PROTEINS;

BIGLYCAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION REGULATION; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL; WOUND CLOSURE;

ANIMALS; BIGLYCAN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FLOW CYTOMETRY; HUMANS; MICE; NIH 3T3 CELLS; RECEPTOR, ERBB-2; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

MURINAE;

EID: 84863798920     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.334425     Document Type: Article

References (47)

1. Schaefer, L., and Iozzo, R. V. (2008) Biological functions of the small leucine- rich proteoglycans. From genetics to signal transduction. J. Biol. Chem. 283, 21305-21309
2. Corsi, A., Xu, T., Chen, X. D., Boyde, A., Liang, J., Mankani, M., Sommer, B., Iozzo, R. V., Eichstetter, I., Robey, P. G., Bianco, P., and Young, M. F. (2002) Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 17, 1180-1189 (Pubitemid 34680494)
3. Kinsella, M. G., Bressler, S. L., and Wight, T. N. (2004) The regulated synthesis of versican, decorin, and biglycan. Extracellular matrix proteoglycans that influence cellular phenotype. Crit. Rev. Eukaryot. Gene Expr. 14, 203-234 (Pubitemid 38931846)
4. Iozzo, R. V., and Schaefer, L. (2010) Proteoglycans in health and disease. Novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J. 277, 3864-3875
5. Roughley, P. J., White, R. J., and Mort, J. S. (1996) Presence of pro-forms of decorin and biglycan in human articular cartilage. Biochem. J. 318, 779-784 (Pubitemid 26320940)
6. Tufvesson, E., and Westergren-Thorsson, G. (2003) Biglycan and decorin induce morphological and cytoskeletal changes involving signaling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration. J. Cell Sci. 116, 4857-4864 (Pubitemid 37541227)
7. Meyer-Kirchrath, J., Martin, M., Schooss, C., Jacoby, C., Flögel, U., Marzoll, A., Fischer, J. W., Schrader, J., Schrör, K., and Hohlfeld, T. (2009) Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart. Cardiovasc. Res. 81, 310-318
8. Weber, C. K., Sommer, G., Michl, P., Fensterer, H., Weimer, M., Gansauge, F., Leder, G., Adler, G., and Gress, T. M. (2001) Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology 121, 657-667 (Pubitemid 32822581)
9. Schaefer, L., Raslik, I., Grone, H. J., Schonherr, E., Macakova, K., Ugorcakova, J., Budny, S., Schaefer, R. M., and Kresse, H. (2001) Small proteoglycans in human diabetic nephropathy. Discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J. 15, 559-561
10. Joyce, J. A., and Pollard, J. W. (2009) Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252
11. Nannuru, K. C., and Singh, R. K. (2010) Tumor-stromal interactions in bone metastasis. Curr. Osteoporos. Rep. 8, 105-113
12. Ruiter, D., Bogenrieder, T., Elder, D., and Herlyn, M. (2002) Melanomastroma interactions. Structural and functional aspects. Lancet Oncol. 3, 35-43 (Pubitemid 34121144)
13. Vuillermoz, B., Khoruzhenko, A., D'Onofrio, M. F., Ramont, L., Venteo, L., Perreau, C., Antonicelli, F., Maquart, F. X., and Wegrowski, Y. (2004) The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp. Cell Res. 296, 294-306 (Pubitemid 38624650)
14. Brézillon, S., Venteo, L., Ramont, L., D'Onofrio, M. F., Perreau, C., Pluot, M., Maquart, F. X., and Wegrowski, Y. (2007) Expression of lumican, a small leucine-rich proteoglycan with antitumor activity, in human malignant melanoma. Clin. Exp. Dermatol. 32, 405-416 (Pubitemid 46828334)
15. Santra, M., Mann, D. M., Mercer, E. W., Skorski, T., Calabretta, B., and Iozzo, R. V. (1997) Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Investig. 100, 149-157 (Pubitemid 27311253)
16. Hocking, A. M., Shinomura, T., and McQuillan, D. J. (1998) Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 17, 1-19 (Pubitemid 28206020)
17. Mathias, R. A., Chen, Y. S., Wang, B., Ji, H., Kapp, E. A., Moritz, R. L., Zhu, H. J., and Simpson, R. J. (2010) Extracellular remodeling during oncogenic Ras-induced epithelial-mesenchymal transition facilitates MDCK cell migration. J. Proteome Res 9, 1007-1019
18. Yoshioka, N., Inoue, H., Nakanishi, K., Oka, K., Yutsudo, M., Yamashita, A., Hakura, A., and Nojima, H. (2000) Isolation of transformation suppressor genes by cDNA subtraction. Lumican suppresses transformation induced by v-src and v-K-ras. J. Virol. 74, 1008-1013 (Pubitemid 30036239)
19. Tchernitsa, O. I., Sers, C., Zuber, J., Hinzmann, B., Grips, M., Schramme, A., Lund, P., Schwendel, A., Rosenthal, A., and Schäfer, R. (2004) Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene 23, 4536-4555 (Pubitemid 38850403)
20. Recktenwald, C. V., Kellner, R., Lichtenfels, R., and Seliger, B. (2008) Altered detoxification status and increased resistance to oxidative stress by K-ras transformation. Cancer Res. 68, 10086-10093
21. Benayahu, D., Shur, I., Marom, R., Meller, I., and Issakov, J. (2001) Cellular and molecular properties associated with osteosarcoma cells. J. Cell. Biochem. 84, 108-114 (Pubitemid 33103763)
22. Hunzelmann, N., Schönherr, E., Bonnekoh, B., Hartmann, C., Kresse, H., and Krieg, T. (1995) Altered immunohistochemical expression of small proteoglycans in the tumor tissue and stroma of basal cell carcinoma. J. Invest. Dermatol. 104, 509-513
23. Skandalis, S. S., Theocharis, A. D., Theocharis, D. A., Papadas, T., Vynios, D. H., and Papageorgakopoulou, N. (2004) Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinoma. Biochim. Biophys. Acta 1689, 152-161 (Pubitemid 38766150)
24. Reed, C. C., Waterhouse, A., Kirby, S., Kay, P., Owens, R. T., McQuillan, D. J., and Iozzo, R. V. (2005) Decorin prevents metastatic spreading of breast cancer. Oncogene 24, 1104-1110 (Pubitemid 40313888)
25. Herrmann, F., Lehr, H. A., Drexler, I., Sutter, G., Hengstler, J., Wollscheid, U., and Seliger, B. (2004) HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway. Cancer Res. 64, 215-220 (Pubitemid 38114101)
26. Mimura, K., Ando, T., Poschke, I., Mougiakakos, D., Johansson, C. C., Ichikawa, J., Okita, R., Nishimura, M. I., Handke, D., Krug, N., Choudhury, A., Seliger, B., and Kiessling, R. (2011) T cell recognition of HLA-A2-restricted tumor antigens is impaired by the oncogene HER2. Int. J. Cancer 128, 390-401
27. Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., Node, M., and Imamura, T. (2005) The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-β. Cancer Sci. 96, 791-800 (Pubitemid 43019830)
28. Delghandi, M. P., Johannessen, M., and Moens, U. (2005) The cAMP signaling pathway activates CREB through PKA, p38, and MSK1 in NIH 3T3 cells. Cell. signal. 17, 1343-1351 (Pubitemid 41206644)
29. Beltman, J., McCormick, F., and Cook, S. J. (1996) The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J. Biol. Chem. 271, 27018-27024 (Pubitemid 26359119)
30. Markou, T., Hadzopoulou-Cladaras, M., and Lazou, A. (2004) Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways. J. Mol. Cell. Cardiol. 37, 1001-1011 (Pubitemid 39446825)
31. Recktenwald, C. V., Mendler, S., Lichtenfels, R., Kellner, R., and Seliger, B. (2007) Influence of Ki-ras-driven oncogenic transformation on the protein network of murine fibroblasts. Proteomics 7, 385-398 (Pubitemid 46293982)
32. Wulfaenger, J., Niedling, S., Riemann, D., and Seliger, B. (2008) Aminopeptidase N (APN)/CD13-dependent CXCR4 down-regulation is associated with diminished cell migration, proliferation, and invasion. Mol. Membr. Biol. 25, 72-82
33. Rodriguez, L. G., Wu, X., and Guan, J. L. (2005) Wound-healing assay. Methods Mol. Biol. 294, 23-29
34. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
35. Ungefroren, H., Groth, S., Ruhnke, M., Kalthoff, H., and Fändrich, F. (2005) Transforming growth factor-β (TGF-β) type I receptor/ALK5-dependent activation of the GADD45β gene mediates the induction of biglycan expression by TGF-β. J. Biol. Chem. 280, 2644-2652 (Pubitemid 40189368)
36. Merline, R., Schaefer, R. M., and Schaefer, L. (2009) The matricellular functions of small leucine-rich proteoglycans (SLRPs). J. Cell Commun. Signal. 3, 323-335
37. Makatsori, E., Lamari, F. N., Theocharis, A. D., Anagnostides, S., Hjerpe, A., Tsegenidis, T., and Karamanos, N. K. (2003) Large matrix proteoglycans, versican and perlecan, are expressed and secreted by human leukemic monocytes. Anticancer Res. 23, 3303-3309 (Pubitemid 36975427)
38. Wang, B., Li, G. X., Zhang, S. G., Wang, Q., Wen, Y. G., Tang, H. M., Zhou, C. Z., Xing, A. Y., Fan, J. W., Yan, D. W., Qiu, G. Q., Yu, Z. H., and Peng, Z. H. (2011) Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. Exp. Biol. Med. (Maywood) 236, 1247-1253
39. Gu, X., Ma, Y., Xiao, J., Zheng, H., Song, C., Gong, Y., and Xing, X. (2011) Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers. Clin. Exp. Med. Doi 10.1007/S10238-011-0155-4
40. Tufvesson, E., Malmström, J., Marko-Varga, G., and Westergren-Thorsson, G. (2002) Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts. Eur. J. Biochem. 269, 3688-3696 (Pubitemid 34989117)
41. Tiede, K., Melchior-Becker, A., and Fischer, J. W. (2010) Transcriptional and posttranscriptional regulators of biglycan in cardiac fibroblasts. Basic Res. Cardiol. 105, 99-108
42. Seidler, D. G., Faiyaz-Ul-Haque, M., Hansen, U., Yip, G. W., Zaidi, S. H., Teebi, A. S., Kiesel, L., and Götte, M. (2006) Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel R270C substitution in galactosyltransferase I (β4GalT-7). J. Mol. Med. 84, 583-594 (Pubitemid 43992850)
43. Nash, M. A., Loercher, A. E., and Freedman, R. S. (1999) In vitro growth inhibition of ovarian cancer cells by decorin. Synergism of action between decorin and carboplatin. Cancer Res. 59, 6192-6196 (Pubitemid 30035642)
44. Datsis, G. A., Berdiaki, A., Nikitovic, D., Mytilineou, M., Katonis, P., Karamanos, N. K., and Tzanakakis, G. N. (2011) Parathyroid hormone affects the fibroblast growth factor-proteoglycan signaling axis to regulate osteosarcoma cell migration. FEBS J. 278, 3782-3792
45. Iacob, S., and Cs-Szabo, G. (2010) Biglycan regulates the expression of EGF receptors through EGF signaling pathways in human articular chondrocytes. Connect. Tissue Res. 51, 347-358
46. Aggarwal, S., Kim, S. W., Ryu, S. H., Chung, W. C., and Koo, J. S. (2008) Growth suppression of lung cancer cells by targeting cyclic AM Presponse element-binding protein. Cancer Res. 68, 981-988 (Pubitemid 351272215)
47. Abramovitch, R., Tavor, E., Jacob-Hirsch, J., Zeira, E., Amariglio, N., Pappo, O., Rechavi, G., Galun, E., and Honigman, A. (2004) A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res. 64, 1338-1346 (Pubitemid 38235602)